Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹8,933 Cr
Revenue (TTM)
₹4,178 Cr
Net Profit (TTM)
₹1 Cr
ROE
0.1 %
ROCE
0.4 %
P/E Ratio
--
P/B Ratio
3.1
Industry P/E
40.79
EV/EBITDA
54.8
Div. Yield
0 %
Debt to Equity
0.7
Book Value
₹49.6
EPS
₹-0.3
Face value
2
Shares outstanding
157,393,988
CFO
₹1,291.84 Cr
EBITDA
₹1,634.57 Cr
Net Profit
₹351.33 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Akums Drugs And Pharmaceuticals
| -11.3 | 11.9 | 14.0 | -- | -- | -- | -- |
|
BSE Healthcare
| -5.9 | 0.5 | 7.3 | 18.6 | 22.8 | 22.3 | 9.5 |
|
BSE Small Cap
| -6.0 | 4.8 | 12.4 | 7.4 | 25.0 | 37.4 | 16.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Akums Drugs And Pharmaceuticals
|
566.1 | 8,932.9 | 4,178.2 | 0.8 | -- | 0.1 | -- | 3.1 |
| 866.4 | 7,850.8 | 2,115.1 | 272.4 | 17.8 | 14.2 | 28.8 | 3.9 | |
| 1,168.8 | 9,569.3 | 1,006.9 | 160.4 | 20.4 | 12.6 | 60.3 | 7.3 | |
| 404.7 | 4,986.3 | 1,859.8 | 90.8 | 10.4 | 7.4 | 54.9 | 4.0 | |
| 890.5 | 5,087.9 | 1,243.7 | 128.3 | 13.0 | 13.8 | 39.7 | 5.3 | |
| 973.2 | 2,402.8 | 356.3 | 100.9 | 25.0 | 13.3 | 23.8 | 3.1 | |
| 262.2 | 2,324.5 | 780.4 | 63.4 | 12.6 | 12 | 35.2 | 3.8 | |
| 163.3 | 5,302.7 | 71.8 | -342.5 | -467.5 | -- | -- | -24.5 | |
| 1,286.1 | 1,817.0 | 801.5 | 81.7 | 3.3 | 6.7 | 22.3 | 1.7 | |
| 999.8 | 2,945.8 | 245.3 | -50.8 | -18.5 | -40.5 | -- | 9.9 |
5 min read•By Hemkesh Khattar
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets,... vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India. Read more
Incorporated
2004
Chairman
--
Managing Director
Sanjeev Jain
Headquarters
Delhi, Delhi
Website
Looking for more details about Akums Drugs And Pharmaceuticals Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Akums Drugs And Pharmaceuticals Ltd stood at ₹ 3,504 Cr as on 31-Mar-24
The share price of Akums Drugs And Pharmaceuticals Ltd is ₹566.05 (NSE) and ₹567.55 (BSE) as of 23-May-2025 IST. Akums Drugs And Pharmaceuticals Ltd has given a return of --% in the last 1 years.
Akums Drugs And Pharmaceuticals Ltd has a market capitalisation of ₹ 8,933 Cr as on 23-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Akums Drugs And Pharmaceuticals Ltd is 3.08 times as on 23-May-2025, a 20% discount to its peers’ median range of 3.85 times.
Since, TTM earnings of Akums Drugs And Pharmaceuticals Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Akums Drugs And Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Akums Drugs And Pharmaceuticals Ltd.
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India.
The prominent promoters of Akums Drugs And Pharmaceuticals Ltd are
| Name of promoters | Holding percentage |
|---|---|
|
AKUMS MASTER TRUST (Sanjeev Jain and Sandeep Jain) |
40.79%
|
|
Sandeep Jain |
17.24%
|
|
Sanjeev Jain |
17.23%
|
The chairman of the company is , and the managing director is Sanjeev Jain.
There is no promoter pledging in Akums Drugs And Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,569
|
|
|
7,851
|
|
|
5,303
|
|
|
5,088
|
|
|
4,986
|
|
|
2,946
|
|
|
2,403
|
|
|
2,324
|
|
|
1,817
|
| Akums Drugs And Pharmaceuticals Ltd | Ratios |
|---|---|
|
Return on equity(%)
|
0.11
|
|
Operating margin(%)
|
-0.06
|
|
Net Margin(%)
|
0.02
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Akums Drugs And Pharmaceuticals Ltd was ₹1 Cr.
₹2.15
(
